Miramar Labs Inc. raised $35.8 million in a Series C funding round, leaving them just shy of their $36 million goal, according to an SEC filing.
The Sunnyvale, Calif.-based company’s claim to fame is miraDry, a laser-based treatment for excessive underarm sweat. The device uses microwave energy to cook sweat glands in two hour-long noninvasive doctor’s office visits.
The company plans to use the funds to begin marketing the device, according to Xconomy.
New investors Aisling Capital and Cross Creek Capital led the round, which was joined by existing investors Domain Associates and Morgenthaler Ventures, Xconomy reported.
The miraDry device won clearance from the U.S. Food & Drug Administration in February.
Here’s a roundup of other dealflow and investment news:
Minerva Surgical Inc. is close to fulfilling a $26.2 million financing round from sales of equity, options, and securities. The company, which develops a device for treating abnormal uterine bleeding, is $8,344 away from their goal. The investments come from 19 parties, according to the filing.
Regenerative medicine company Regenesis Biomedical Inc. closed a $5.3 million Series C equity financing round, led by Fulcrum Equity Partners and TGap Ventures, and including prior investor Solstice Capital. The company plans to use the funds to expand its sales force and payer sources, according to the release.
Vycor Medical Inc. (OTC:VYCO) closed a $1.6 million financing round in sales of preferred shares and warrants, part of a prior agreement with Fountainhead Capital Management Limited as a result of the company’s acquisition by NovaVision Inc. Vycor designs devices to work with brain and spinal surgeries.
PolyRemedy Inc. raised $8 million of a $10 million sought in a Series C equity round. The Mountain View, Calif.-based company deals in customized dressing for patients with chronic wounds, like diabetic ulcers.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!